115
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts

, , , , , , , & show all
Pages 3007-3015 | Published online: 16 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hanumanth Srikanth Cheruvu, Xin Liu, Jeffrey E. Grice & Michael S. Roberts. (2020) Modeling percutaneous absorption for successful drug discovery and development. Expert Opinion on Drug Discovery 15:10, pages 1181-1198.
Read now

Articles from other publishers (12)

Hao Wu, Xuefeng Ding, Yun Chen, Yanfei Cai, Zhaoqi Yang, Qinghe Xu & Jian Jin. (2023) Analysis of the in vitro function and internalization ability of a humanized EGFR antibody AE01 expressed by Chinese hamster ovary cells. Protein Expression and Purification 206, pages 106243.
Crossref
Jeffrey M. Levine, Barbara Delmore & Jill Cox. (2022) Skin Failure: Concept Review and Proposed Model. Advances in Skin & Wound Care 35:3, pages 139-148.
Crossref
Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, Lisa Salvatore, Roberto Filippi, Michele Ghidini, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Emanuela Dell’Aquila, Pasquale Lombardi, Susana Roselló Keränen, Ilaria Depetris, Riccardo Giampieri, Cristina Morelli, Michele De Tursi, Francesca Romana Di Pietro, Nicoletta Zanaletti, Pasquale Vitale, Ingrid Garajova, Gian Paolo Spinelli, Federica Zoratto, Michela Roberto, Angelica Petrillo, Giacomo Aimar, Alessio Cortellini, Maria Vittoria Pensieri, Corrado Ficorella, Claudio Ferri & Alessandro Parisi. (2021) A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?. Supportive Care in Cancer 30:3, pages 2455-2465.
Crossref
Náthali Felícia Mineiro dos Santos Garrett, Ana Cristina Carvalho da Costa, Elaine Barros Ferreira, Giovanni Damiani, Paula Elaine Diniz dos Reis & Christiane Inocêncio Vasques. (2021) Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis. PLOS ONE 16:8, pages e0255716.
Crossref
Ann Goodey. (2021) The impact of chemotherapy on skin health in relation to stoma care. Gastrointestinal Nursing 19:6, pages 30-34.
Crossref
R. T. Lugtenberg, C. B. Boers-Doets, P. O. Witteveen, C. M. L. van Herpen, A. N. M. Wymenga, J. W. B. de Groot, A. Hoeben, C. del Grande, B. van Doorn, J. J. Koldenhof, C. M. L. Driessen & H. Gelderblom. (2020) Prospective practice survey of management of cetuximab-related skin reactions. Supportive Care in Cancer 29:7, pages 3497-3506.
Crossref
Siu-Fun Wong, Joseph M. Unger, James L. WadeIIIIII, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn Arnold, Mario R. VelascoJrJr, Justin D. Floyd, Benjamin T. Esparaz, Afsaneh Barzi, Heinz-Josef Lenz, Marianna Koczywas, Shaker Dakhil, Gary V. Burton, Michael J. Fisch, N. Lynn Henry, Dawn L. Hershman & Carol M. Moinpour. (2020) A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. Journal of Patient-Reported Outcomes 4:1.
Crossref
Kathleen Wiley, George Ebanks Jr.Gary Shelton, Jenna Strelo & Kathryn Ciccolini. (2020) Skin Toxicity: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Skin Toxicity. Clinical Journal of Oncology Nursing 24:5, pages 561-565.
Crossref
Ting-Yu Chiang, Hung-Chih Hsu, Sui-Whi Jane & Shu-Ching Chen. (2020) EGFRI-associated health-related quality of life by severity of skin toxicity in metastatic colorectal cancer patients receiving epidermal growth factor receptor inhibitor target therapy. Supportive Care in Cancer 28:10, pages 4771-4779.
Crossref
Kengo Hirayama, Ya Su, Megumi Chiba, Miku Izutsu & Michiko Yuki. (2020) Relationships between quality of life and skin toxicities of epidermal growth factor receptor inhibitors in cancer patients: A literature review. Japan Journal of Nursing Science 17:3.
Crossref
Kimberly A. Lowe, Laura Sangaré, Rachel Bergstresser, Michelle McNamara, George Kafatos & Tamer Garawin. (2019) A National Survey of Medical Oncologist’s Opinions and Perceptions for Managing Rash Among mCRC Patients Treated with Panitumumab. Dermatology and Therapy 9:2, pages 337-353.
Crossref
Yanmei Peng, Qiang Li, Jingyi Zhang, Wen Shen, Xu Zhang, Chenyao Sun & Huijuan Cui. (2018) Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors. BioScience Trends 12:6, pages 537-552.
Crossref